<?xml version='1.0' encoding='utf-8'?>
<document id="31118708"><sentence text="Drug-drug interaction study of imatinib and voriconazole in vitro and in vivo."><entity charOffset="31-39" id="DDI-PubMed.31118708.s1.e0" text="imatinib" /><entity charOffset="44-56" id="DDI-PubMed.31118708.s1.e1" text="voriconazole" /><pair ddi="false" e1="DDI-PubMed.31118708.s1.e0" e2="DDI-PubMed.31118708.s1.e0" /><pair ddi="false" e1="DDI-PubMed.31118708.s1.e0" e2="DDI-PubMed.31118708.s1.e1" /></sentence><sentence text="Background: In clinical practice, common problem polypharmacy could result in the increased risks of drug-drug interactions (DDIs)" /><sentence text=" Co-administered imatinib (IMA) and voriconazole (VOR) as one treatment protocol in cancer patients with fungal infections are common"><entity charOffset="17-25" id="DDI-PubMed.31118708.s3.e0" text="imatinib" /><entity charOffset="27-30" id="DDI-PubMed.31118708.s3.e1" text="IMA" /><entity charOffset="36-48" id="DDI-PubMed.31118708.s3.e2" text="voriconazole" /><entity charOffset="50-53" id="DDI-PubMed.31118708.s3.e3" text="VOR" /><pair ddi="false" e1="DDI-PubMed.31118708.s3.e0" e2="DDI-PubMed.31118708.s3.e0" /><pair ddi="false" e1="DDI-PubMed.31118708.s3.e0" e2="DDI-PubMed.31118708.s3.e1" /><pair ddi="false" e1="DDI-PubMed.31118708.s3.e0" e2="DDI-PubMed.31118708.s3.e2" /><pair ddi="false" e1="DDI-PubMed.31118708.s3.e0" e2="DDI-PubMed.31118708.s3.e3" /><pair ddi="false" e1="DDI-PubMed.31118708.s3.e1" e2="DDI-PubMed.31118708.s3.e1" /><pair ddi="false" e1="DDI-PubMed.31118708.s3.e1" e2="DDI-PubMed.31118708.s3.e2" /><pair ddi="false" e1="DDI-PubMed.31118708.s3.e1" e2="DDI-PubMed.31118708.s3.e3" /><pair ddi="false" e1="DDI-PubMed.31118708.s3.e2" e2="DDI-PubMed.31118708.s3.e2" /><pair ddi="false" e1="DDI-PubMed.31118708.s3.e2" e2="DDI-PubMed.31118708.s3.e3" /></sentence><sentence text="Purpose: The aim of the present study was to assess the potential DDIs associated with the concurrent use of IMA and VOR in rat liver microsomes (RLMs) and in rats"><entity charOffset="109-111" id="DDI-PubMed.31118708.s4.e0" text="IMA" /><entity charOffset="117-119" id="DDI-PubMed.31118708.s4.e1" text="VOR" /><pair ddi="false" e1="DDI-PubMed.31118708.s4.e0" e2="DDI-PubMed.31118708.s4.e0" /><pair ddi="false" e1="DDI-PubMed.31118708.s4.e0" e2="DDI-PubMed.31118708.s4.e1" /></sentence><sentence text="Methods and results: The concentration levels of IMA, VOR, and their metabolites N-desmethyl IMA (CGP74588) and N-oxide voriconazole (N-oxide VOR) were determined by ultra performance liquid chromatography-tandem mass spectrometry"><entity charOffset="54-57" id="DDI-PubMed.31118708.s5.e0" text="VOR" /><entity charOffset="81-96" id="DDI-PubMed.31118708.s5.e1" text="N-desmethyl IMA" /><entity charOffset="98-106" id="DDI-PubMed.31118708.s5.e2" text="CGP74588" /><entity charOffset="112-132" id="DDI-PubMed.31118708.s5.e3" text="N-oxide voriconazole" /><entity charOffset="134-141" id="DDI-PubMed.31118708.s5.e4" text="N-oxide" /><entity charOffset="49-55" id="DDI-PubMed.31118708.s5.e5" text="IMA" /><entity charOffset="93-99" id="DDI-PubMed.31118708.s5.e6" text="IMA" /><entity charOffset="142-148" id="DDI-PubMed.31118708.s5.e7" text="VOR" /><pair ddi="false" e1="DDI-PubMed.31118708.s5.e5" e2="DDI-PubMed.31118708.s5.e5" /><pair ddi="false" e1="DDI-PubMed.31118708.s5.e5" e2="DDI-PubMed.31118708.s5.e0" /><pair ddi="false" e1="DDI-PubMed.31118708.s5.e5" e2="DDI-PubMed.31118708.s5.e1" /><pair ddi="false" e1="DDI-PubMed.31118708.s5.e5" e2="DDI-PubMed.31118708.s5.e6" /><pair ddi="false" e1="DDI-PubMed.31118708.s5.e5" e2="DDI-PubMed.31118708.s5.e2" /><pair ddi="false" e1="DDI-PubMed.31118708.s5.e5" e2="DDI-PubMed.31118708.s5.e3" /><pair ddi="false" e1="DDI-PubMed.31118708.s5.e5" e2="DDI-PubMed.31118708.s5.e4" /><pair ddi="false" e1="DDI-PubMed.31118708.s5.e5" e2="DDI-PubMed.31118708.s5.e7" /><pair ddi="false" e1="DDI-PubMed.31118708.s5.e0" e2="DDI-PubMed.31118708.s5.e0" /><pair ddi="false" e1="DDI-PubMed.31118708.s5.e0" e2="DDI-PubMed.31118708.s5.e1" /><pair ddi="false" e1="DDI-PubMed.31118708.s5.e0" e2="DDI-PubMed.31118708.s5.e6" /><pair ddi="false" e1="DDI-PubMed.31118708.s5.e0" e2="DDI-PubMed.31118708.s5.e2" /><pair ddi="false" e1="DDI-PubMed.31118708.s5.e0" e2="DDI-PubMed.31118708.s5.e3" /><pair ddi="false" e1="DDI-PubMed.31118708.s5.e0" e2="DDI-PubMed.31118708.s5.e4" /><pair ddi="false" e1="DDI-PubMed.31118708.s5.e0" e2="DDI-PubMed.31118708.s5.e7" /><pair ddi="false" e1="DDI-PubMed.31118708.s5.e1" e2="DDI-PubMed.31118708.s5.e1" /><pair ddi="false" e1="DDI-PubMed.31118708.s5.e1" e2="DDI-PubMed.31118708.s5.e6" /><pair ddi="false" e1="DDI-PubMed.31118708.s5.e1" e2="DDI-PubMed.31118708.s5.e2" /><pair ddi="false" e1="DDI-PubMed.31118708.s5.e1" e2="DDI-PubMed.31118708.s5.e3" /><pair ddi="false" e1="DDI-PubMed.31118708.s5.e1" e2="DDI-PubMed.31118708.s5.e4" /><pair ddi="false" e1="DDI-PubMed.31118708.s5.e1" e2="DDI-PubMed.31118708.s5.e7" /><pair ddi="false" e1="DDI-PubMed.31118708.s5.e6" e2="DDI-PubMed.31118708.s5.e6" /><pair ddi="false" e1="DDI-PubMed.31118708.s5.e6" e2="DDI-PubMed.31118708.s5.e2" /><pair ddi="false" e1="DDI-PubMed.31118708.s5.e6" e2="DDI-PubMed.31118708.s5.e3" /><pair ddi="false" e1="DDI-PubMed.31118708.s5.e6" e2="DDI-PubMed.31118708.s5.e4" /><pair ddi="false" e1="DDI-PubMed.31118708.s5.e6" e2="DDI-PubMed.31118708.s5.e7" /><pair ddi="false" e1="DDI-PubMed.31118708.s5.e2" e2="DDI-PubMed.31118708.s5.e2" /><pair ddi="false" e1="DDI-PubMed.31118708.s5.e2" e2="DDI-PubMed.31118708.s5.e3" /><pair ddi="false" e1="DDI-PubMed.31118708.s5.e2" e2="DDI-PubMed.31118708.s5.e4" /><pair ddi="false" e1="DDI-PubMed.31118708.s5.e2" e2="DDI-PubMed.31118708.s5.e7" /><pair ddi="false" e1="DDI-PubMed.31118708.s5.e3" e2="DDI-PubMed.31118708.s5.e3" /><pair ddi="false" e1="DDI-PubMed.31118708.s5.e3" e2="DDI-PubMed.31118708.s5.e4" /><pair ddi="false" e1="DDI-PubMed.31118708.s5.e3" e2="DDI-PubMed.31118708.s5.e7" /><pair ddi="false" e1="DDI-PubMed.31118708.s5.e4" e2="DDI-PubMed.31118708.s5.e4" /><pair ddi="false" e1="DDI-PubMed.31118708.s5.e4" e2="DDI-PubMed.31118708.s5.e7" /></sentence><sentence text=" In vitro study of RLMs, VOR inhibited the IMA metabolism with the half-maximal inhibitory concentration (IC50) of 105"><entity charOffset="43-45" id="DDI-PubMed.31118708.s6.e0" text="IMA" /><entity charOffset="25-27" id="DDI-PubMed.31118708.s6.e1" text="VOR" /><pair ddi="false" e1="DDI-PubMed.31118708.s6.e1" e2="DDI-PubMed.31118708.s6.e1" /><pair ddi="false" e1="DDI-PubMed.31118708.s6.e1" e2="DDI-PubMed.31118708.s6.e0" /></sentence><sentence text="20 μM, while IC50 for IMA against VOR was 61"><entity charOffset="22-24" id="DDI-PubMed.31118708.s7.e0" text="IMA" /><entity charOffset="34-36" id="DDI-PubMed.31118708.s7.e1" text="VOR" /><pair ddi="false" e1="DDI-PubMed.31118708.s7.e0" e2="DDI-PubMed.31118708.s7.e0" /><pair ddi="false" e1="DDI-PubMed.31118708.s7.e0" e2="DDI-PubMed.31118708.s7.e1" /></sentence><sentence text="30 μM" /><sentence text=" After co-administered IMA and VOR in rats, the Cmax of IMA was increased significantly, while the AUC0→t, AUC0→∞, and Cmax of CGP74588 were decreased significantly"><entity charOffset="23-25" id="DDI-PubMed.31118708.s9.e0" text="IMA" /><entity charOffset="56-58" id="DDI-PubMed.31118708.s9.e1" text="IMA" /><entity charOffset="31-33" id="DDI-PubMed.31118708.s9.e2" text="VOR" /><pair ddi="false" e1="DDI-PubMed.31118708.s9.e0" e2="DDI-PubMed.31118708.s9.e0" /><pair ddi="false" e1="DDI-PubMed.31118708.s9.e0" e2="DDI-PubMed.31118708.s9.e2" /><pair ddi="false" e1="DDI-PubMed.31118708.s9.e0" e2="DDI-PubMed.31118708.s9.e1" /><pair ddi="false" e1="DDI-PubMed.31118708.s9.e2" e2="DDI-PubMed.31118708.s9.e2" /><pair ddi="false" e1="DDI-PubMed.31118708.s9.e2" e2="DDI-PubMed.31118708.s9.e1" /></sentence><sentence text=" In addition, similar results were also found that the main pharmacokinetic parameters (AUC0→t, AUC0→∞, MRT0→∞, Tmax, and Cmax) of VOR were increased significantly, while the AUC0→t, AUC0→∞, and Cmax of N-oxide VOR were decreased significantly"><entity charOffset="203-210" id="DDI-PubMed.31118708.s10.e0" text="N-oxide" /><entity charOffset="131-137" id="DDI-PubMed.31118708.s10.e1" text="VOR" /><entity charOffset="211-217" id="DDI-PubMed.31118708.s10.e2" text="VOR" /><pair ddi="false" e1="DDI-PubMed.31118708.s10.e1" e2="DDI-PubMed.31118708.s10.e1" /><pair ddi="false" e1="DDI-PubMed.31118708.s10.e1" e2="DDI-PubMed.31118708.s10.e0" /><pair ddi="false" e1="DDI-PubMed.31118708.s10.e1" e2="DDI-PubMed.31118708.s10.e2" /><pair ddi="false" e1="DDI-PubMed.31118708.s10.e0" e2="DDI-PubMed.31118708.s10.e0" /><pair ddi="false" e1="DDI-PubMed.31118708.s10.e0" e2="DDI-PubMed.31118708.s10.e2" /></sentence><sentence text=" Incorporation of all the results indicated that both drugs had a inhibitory effect on each other's metabolism in vitro and in vivo" /><sentence text="Conclusion: Thus, it is of great value to monitor the concomitant use of IMA and VOR in the clinic to reduce the risks of unexpected clinical outcomes"><entity charOffset="73-75" id="DDI-PubMed.31118708.s12.e0" text="IMA" /><entity charOffset="81-83" id="DDI-PubMed.31118708.s12.e1" text="VOR" /><pair ddi="false" e1="DDI-PubMed.31118708.s12.e0" e2="DDI-PubMed.31118708.s12.e0" /><pair ddi="false" e1="DDI-PubMed.31118708.s12.e0" e2="DDI-PubMed.31118708.s12.e1" /></sentence><sentence text="" /></document>